Tag: Trump administration

Trump’s GLP-1 Drug Deal with Eli Lilly and Novo Nordisk Falls Short of Cost Control Goals

The Trump administration's voluntary pricing agreement with Eli Lilly and Novo Nordisk to control GLP-1 drug costs contains structural loopholes…

Trump Administration Proposes Rule to Close Medicare Drug Price Negotiation Loophole

Trump administration proposes rule to close Medicare drug price negotiation loophole, potentially affecting 65 million beneficiaries. Policy targets pharmaceutical industry…

New ACA Rule Allows 30% Higher Deductibles While Expanding Plan Options

Trump administration finalizes ACA rule allowing 30% higher out-of-pocket costs while introducing network-free plan options. New regulation expands consumer choice…

Montana’s Medicaid Work Requirements Return as State Faces Budget Pressures Under Trump

Montana prepares to reimpose Medicaid work requirements as budget pressures mount and Trump administration signals federal support. The state faces…

Trump Drug Pricing Deals Face First Test as New Medications Launch

President Trump's most-favored-nation drug pricing agreements with 17 pharmaceutical companies face their first real-world test as new medications launch. Healthcare…

Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network